greatly contracted by trade impacts and the higher For three months For nine months Consolidated financial statement ended 31st December ended 31st December Oct - Dec 2019 Oct - Dec 2018 Change % Change Apr
consolidated financial statement of the Company as of 30 September 2019 as follows: (a) Net Tangible Asset Not Applicable (b) Net Profit from Operations Not Applicable (c) Compare to Total Value of consideration
Assets Statement of Financial Position March 31, 2020 December 31, 2019 Increased / (Decreased) Million Baht % Million Baht % Million Baht % Current Assets 2,011.25 60.47% 1,837.49 54.88% 173.77 9.46% Non
to WHAUP Profit and Loss Statement in 1Q2019. 8 Definition of Normalized Net Income attributable to Owners of the Parent is changed to Net Profit attributable to Owners of the Parent excluding Foreign
subsidiaries as details below: (Unit: Baht millions) For the year ended 31st March Consolidated financial statement Apr 2019 - Mar 2020 Apr 2018 - Mar 2019 Change % Change Revenue from sales & service 2,756.44
June 2020 of the Company and its subsidiaries as details below: (Unit: Baht millions) For the period of three months Consolidated financial statement ended 30th June Apr 2020 - June 2020 Apr 2019 - June
“Company”) submitted its separate financial statement and its consolidated financial statement for the second quarter of 2020 ended on 30 June 2020 which were reviewed by the auditor. The Company hereby
(Previous: January to December), following to the approval of shareholders’ meeting held on 24 April 2019. Therefore, the statement of comprehensive income will demonstrate the performance of 12-month ended
service of the MRT Blue Line, the Company recorded interest cost of the project, which formerly recorded as cost of construction, as interest expenses in the income statement according to accounting
9/11 Summary of financial statement of Medical Vision Company Limited as of 31 December 2019 Item Value (Baht) Total Assets 25,390,781.70 Total Liabilities 22,670,829.42 Total Shareholders' Equity